Stockscreener 앱 받기
1.49
0.67%
-0.01
전일 마감가:
$1.50
열려 있는:
$1.51
하루 거래량:
430.94K
Relative Volume:
0.75
시가총액:
$147.91M
수익:
$13.56M
순이익/손실:
$-35.57M
주가수익비율:
-3.3498
EPS:
-0.4448
순현금흐름:
$-29.13M
1주 성능:
-3.87%
1개월 성능:
+14.62%
6개월 성능:
+41.90%
1년 성능:
+157.83%
1일 변동 폭
$1.47
$1.539
1주일 범위
$1.37
$1.539
52주 변동 폭
$0.5327
$2.22
Hyperfine Inc Stock (HYPR) Company Profile
명칭
Hyperfine Inc
전화
866-796-6767
주소
351 NEW WHITFIELD STREET, GUILFORD
Compare HYPR vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
HYPR
Hyperfine Inc
|
1.49 | 148.91M | 13.56M | -35.57M | -29.13M | -0.4448 |
ABT
Abbott Laboratories
|
87.41 | 152.88B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
316.48 | 120.18B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.60 | 100.34B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.78 | 84.95B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
85.78 | 47.91B | 6.30B | 1.07B | 1.09B | 1.8406 |
Hyperfine Inc Stock (HYPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2022-08-11 | 다운그레이드 | Wells Fargo | Overweight → Equal Weight |
| 2022-05-31 | 개시 | Evercore ISI | Outperform |
| 2022-04-14 | 개시 | Wells Fargo | Overweight |
Hyperfine Inc 주식(HYPR)의 최신 뉴스
[Form 4] Hyperfine, Inc. Insider Trading Activity - Stock Titan
Hyperfine (HYPR) director Dan Wolterman receives 157,700 stock options at $1.49 strike - Stock Titan
Hyperfine (HYPR) director awarded 157,700 stock options at $1.49 - Stock Titan
Hyperfine (HYPR) 10% owner Jonathan Rothberg awarded 157,700 stock options - Stock Titan
Hyperfine Announces Presentation of Results from the PRIME Study Showing Portable MRI Substantially Reduces Time to Imaging in Emergency Departments - 01net
Earnings Preview: Hyperfine to Report Financial Results Post-market on May 12 - Moomoo
[EFFECT] Hyperfine, Inc. SEC Filing - Stock Titan
Hyperfine (HYPR) shareholders reelect board and ratify Grant Thornton as 2026 auditor - Stock Titan
Hyperfine Inc stock (US44917L1098): portable MRI specialist in focus after latest quarterly update - AD HOC NEWS
Hyperfine, Inc. (NASDAQ:HYPR) Analysts Are Pretty Bullish On The Stock After Recent Results - simplywall.st
Hyperfine, Inc. (HYPR) reports Q1 loss, beats revenue estimates - MSN
Hyperfine Inc. Earnings Call Highlights Rapid Growth - TipRanks
Hyperfine targets $20M-$22M 2026 revenue while maintaining 50%-55% gross margin - MSN
Hyperfine, Inc. Reports First Quarter 2026 Financial Results - The National Law Review
Hyperfine net loss for first quarter of 2026 hits USD 8.62M - Medical Buyer
Hyperfine, Inc. (NASDAQ:HYPR) Q1 2026 Earnings Call Transcript - Insider Monkey
AI In Medical Imaging Market Expected to Witness Rapid Expansion - openPR.com
Hyperfine Q1 2026 Earnings Call Transcript - Sahm
Hyperfine 1Q Loss/Shr 9c >HYPR - Moomoo
Hyperfine (HYPR) Eps Diluted (TTM) - Zacks Investment Research
Hyperfine, Inc. 2026 Q1ResultsEarnings Call Presentation (NASDAQ:HYPR) 2026-05-12 - Seeking Alpha
Hyperfine reports Q1 EPS (9c), consensus (9c) - TipRanks
Hyperfine Q1 Earnings Call Highlights - MarketBeat
Hyperfine Inc. (HYPR) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Earnings call transcript: Hyperfine Q1 2026 revenue beats forecasts By Investing.com - Investing.com South Africa
Hyperfine Incfiles to register up to 1.2 million shares of class A common stock by selling securityholdersSEC filing - marketscreener.com
Earnings call transcript: Hyperfine Q1 2026 revenue beats forecasts - Investing.com
Hyperfine Continues to Expect Cash Burn for 2026 to Be Approximately $26M to $28 M >HYPR - Moomoo
HYPR: Q1 revenue up 83% year-over-year, with strong margin and robust 2026 growth outlook reiterated - TradingView
Hyperfine, Inc. (HYPR) Reports Q1 Loss, Beats Revenue Estimates - Yahoo Finance
Hyperfine Reports Strong Q1 Revenue Beat, Narrows Loss, and Extends Cash Runway (NASDAQ:HYPR) - ChartMill
HYPERFINE ($HYPR) Releases Q1 2026 Earnings - Quiver Quantitative
Hyperfine (NASDAQ: HYPR) registers 1.083M resale shares from warrant issuance - Stock Titan
Hyperfine, Inc. 1Q 2026: Revenue $3.903M, EPS $(0.09) — 10-Q Summary - TradingView
Hyperfine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Hyperfine (NASDAQ: HYPR) posts 83% Q1 revenue growth but stays unprofitable - Stock Titan
Hyperfine, Inc. Reaffirms Earnings Guidance for the Full Year 2026 - marketscreener.com
This Hyperfine analyst begins coverage on a bullish note; here are top 3 initiations for Wednesday - MSN
Hyperfine Inc expected to post a loss of 9 cents a shareEarnings Preview - TradingView
BTIG Initiates Coverage of Hyperfine, Inc. (HYPR) With a Bullish Outlook - Insider Monkey
Number of shareholders of Hyperfine, Inc. – NASDAQ:HYPR - TradingView
Hyperfine, Inc. to Participate in Jefferies Global Healthcare Conference on May 6, 2026 - geneonline.com
Hyperfine, Inc. to Participate in Upcoming 2026 Jefferies Global Healthcare Conference - Business Wire
Hyperfine (HYPR) price target increased by 24.24% to 2.09 - MSN
Top 10 Hot Penny Stocks to Buy Now - Insider Monkey
Hyperfine (HYPR) to Release Quarterly Earnings on Tuesday - MarketBeat
BTIG initiates coverage of Hyperfine (HYPR) with buy recommendation - MSN
Short Interest in Hyperfine, Inc. (NASDAQ:HYPR) Drops By 15.3% - MarketBeat
This Hyperfine Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Wednesday - Sahm
Hyperfine Swoop System Introduced as India's First Portable MRI for Bedside Brain Imaging at the Country's Leading Medical Institution - marketscreener.com
BTIG initiates Hyperfine stock with buy rating on MRI technology By Investing.com - Investing.com Nigeria
Hyperfine Inc (HYPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.22%
1.41%
자본화:
|
볼륨(24시간):